ClinicalTrials.Veeva

Menu

Association Between Pococyturia and Pre-eclampsia Severity (PEPOD2)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Pre-Eclampsia

Treatments

Other: Dosage of urinary podocyturia

Study type

Observational

Funder types

Other

Identifiers

NCT03316391
69HCL17_0517

Details and patient eligibility

About

Pre-eclampsia is an hypertensive disorder appearing during pregnancy, inducing serious maternal, fetal and neonatal mortality and morbidity. Twenty four hours proteinuria is a key element to define pre-eclampsia severity but is delaying the result by 24 hours and constraining for the patient. A simple and rapid indicator for severe preeclampsia would help clinicians to make appropriate decision in patient management. We hypothesized that urinary podocyturia is correlated to preeclampsia severity. This is a prospective, non-interventional, monocentric study.

Enrollment

14 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women aged 18 years or more
  • single pregnancy
  • admission for pre-eclampsia
  • patient receiving information and non-opposition to participate

Exclusion criteria

  • multiple pregnancy
  • in utero fetal demise excepted if associated with pre-eclampsia
  • antecedent of nephropathy
  • fetal malformation, chromosomal anomalies
  • inability to understand information provided
  • prisoner or under administrative supervision

Trial design

14 participants in 1 patient group

Pre-eclampsia
Description:
Patients in hospital for pre-eclampsia at the Hopital Femme-Mère-Enfant
Treatment:
Other: Dosage of urinary podocyturia

Trial contacts and locations

2

Loading...

Central trial contact

Muriel DORET-DION, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems